Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Precision BioSciences

Explore full profile

A gene editing company specializing in in vivo gene editing with its ARCUS platform

Durham, United StatesFounded 2006Biotech & Life Sciences
Valuation $85M Market cap · Aug/2026
Revenue $19M Latest reported FY

At a glance

Founded
2006
Headquarters
Durham, United States
Listing
IPO 2019
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Investors

18 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A8 investors entered at this stage

Series B and later10 investors entered at this stage

Employees mapped 97 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 31 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
7.7K monthly visits
across markets
🇺🇸 United States70.1%
🇩🇪 Germany9.1%
🇮🇳 India9.1%
🇯🇵 Japan6.5%
🇨🇦 Canada6.5%
Top 5 markets shown

Patents

Estimated portfolio value
$71M

38 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Precision BioSciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Precision BioSciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.